Form 4: Edgewell Personal Care Director James C. Johnson Reports Acquisition of Restricted Stock Equivalents

Director James C. Johnson reports acquisition of 4,999 restricted stock equivalents convertible to Edgewell Common Stock.

Summary

• On February 6, 2025, James C. Johnson, a director of Edgewell Personal Care Co, acquired 4,999 restricted stock equivalents.
• These restricted stock equivalents convert into shares of Edgewell Common Stock the day before the next annual shareholder meeting, unless Johnson defers conversion until his service on the board ends.
• Following the transaction, Johnson beneficially owns 4,999 derivative securities.
• The restricted stock equivalents were acquired on 02/06/2025 and expire on 02/04/2026.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.

Future Outlook

The restricted stock equivalents will convert into shares of Edgewell Common Stock on the day preceding the next annual meeting of shareholders, unless the Reporting Person elects to defer conversion until termination of service on Edgewell's Board of Directors.

Industry Context

This filing is a routine disclosure of a director's acquisition of company stock, which is a common practice in publicly traded companies. It provides transparency to investors regarding the holdings of company insiders.

Stakeholder Impact

• The acquisition of restricted stock equivalents by a director may signal confidence in the company's future performance to shareholders.

Key Dates

Keywords

Edgewell Personal Care, Director, Restricted Stock Equivalents, Form 4, Beneficial Ownership, EPC